• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

各种商业基于生物的鼻咽癌治疗计划系统的成本函数评估。

Various cost functions evaluation of commercial biologically based treatment planning system for nasopharyngeal cancer.

机构信息

Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.

Istanbul Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Turkey.

出版信息

Med Dosim. 2022;47(2):184-190. doi: 10.1016/j.meddos.2022.02.001. Epub 2022 Mar 8.

DOI:10.1016/j.meddos.2022.02.001
PMID:35272889
Abstract

The aim of this study was to evaluate various combinations of Equivalent Uniform Dose (EUD) based and Dose Volume based (DV) cost functions in terms of target coverage and organ sparing for Nasopharyngeal CA. Ten patients diagnosed with Nasopharyngeal CA were selected for this retrospective study. Different hybrid VMAT plans, including EUD- and DV-based cost functions, were generated for each patient to determine the optimum combination in terms of organ sparing and target coverage. The generated VMAT plans were evaluated based on physical and biological dose parameters. No statistical difference was observed among all plans in terms of target coverage. The p values were ≥ 0.005 for V95, D, and tumor control probability (TCP). The MU efficiency was maximum (67%), and the number of segments (285 segments) was minimum in Hybrid plan. Hybrid plan showed a significant difference compared to others (p = 0.001) in terms of serial organs. Moreover, the combination of serial and parallel complication models provided better reduction of radiation dose in the parotid glands in Plan-3 (p = 0.001). In this study, better protection was obtained when DVH-based cost functions were defined for targets and a combination of EUD- and DVH-based cost functions were used for OARs.

摘要

本研究旨在评估基于等效均匀剂量(EUD)和剂量体积(DV)的成本函数的各种组合,以评估鼻咽癌的靶区覆盖和器官保护。选取 10 例鼻咽癌患者进行回顾性研究。为每位患者生成不同的混合 VMAT 计划,包括基于 EUD 和 DV 的成本函数,以确定在器官保护和靶区覆盖方面的最佳组合。基于物理和生物剂量参数对生成的 VMAT 计划进行评估。所有计划在靶区覆盖方面均无统计学差异。V95、D 和肿瘤控制概率(TCP)的 p 值均≥0.005。MU 效率最高(67%),段数最少(285 段)。与其他计划相比,混合计划在序列器官方面有显著差异(p=0.001)。此外,在计划 3 中,串联和并行并发症模型的组合在腮腺中提供了更好的辐射剂量降低(p=0.001)。在本研究中,当为靶区定义基于剂量体积的成本函数,以及为 OAR 使用基于等效均匀剂量和剂量体积的成本函数组合时,可获得更好的保护。

相似文献

1
Various cost functions evaluation of commercial biologically based treatment planning system for nasopharyngeal cancer.各种商业基于生物的鼻咽癌治疗计划系统的成本函数评估。
Med Dosim. 2022;47(2):184-190. doi: 10.1016/j.meddos.2022.02.001. Epub 2022 Mar 8.
2
Comparing biological and physical cost functions in VMAT planning for pediatric nasopharyngeal cancer.比较儿童鼻咽癌调强适形放疗计划中生物和物理代价函数。
J Med Imaging Radiat Sci. 2023 Sep;54(3):473-480. doi: 10.1016/j.jmir.2023.07.002. Epub 2023 Jul 21.
3
Application of dose-volume histogram prediction in biologically related models for nasopharyngeal carcinomas treatment planning.剂量体积直方图预测在鼻咽癌治疗计划生物学相关模型中的应用。
Radiat Oncol. 2020 Sep 15;15(1):216. doi: 10.1186/s13014-020-01623-2.
4
Evaluation of dose-volume histogram prediction for organ-at risk and planning target volume based on machine learning.基于机器学习的危及器官和计划靶区剂量-体积直方图预测评估。
Sci Rep. 2021 Feb 4;11(1):3117. doi: 10.1038/s41598-021-82749-5.
5
Comparison of biological-based and dose volume-based intensity-modulated radiotherapy plans generated using the same treatment planning system.使用同一治疗计划系统生成的基于生物学和基于剂量体积的调强放射治疗计划的比较。
J Cancer Res Ther. 2019 Mar;15(Supplement):S33-S38. doi: 10.4103/jcrt.JCRT_956_16.
6
Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.确定鼻咽癌在调强放射治疗期间进行自适应放射治疗的合适时机。
Radiat Oncol. 2015 Sep 17;10:192. doi: 10.1186/s13014-015-0498-1.
7
Nasopharyngeal carcinoma radiotherapy with hybrid technique.鼻咽癌的混合技术放射治疗
Med Dosim. 2019;44(3):251-257. doi: 10.1016/j.meddos.2018.09.003. Epub 2018 Oct 23.
8
Dose-volume histogram prediction in volumetric modulated arc therapy for nasopharyngeal carcinomas based on uniform-intensity radiation with equal angle intervals.基于等角度间隔均匀强度放射的鼻咽癌容积调强弧形治疗中的剂量-体积直方图预测。
Phys Med Biol. 2019 Dec 5;64(23):23NT03. doi: 10.1088/1361-6560/ab5433.
9
Comparative evaluation of treatment plan quality for a prototype biology-guided radiotherapy system in the treatment of nasopharyngeal carcinoma.原型生物引导放射治疗系统治疗鼻咽癌的治疗计划质量的比较评估。
Med Dosim. 2021;46(2):171-178. doi: 10.1016/j.meddos.2020.11.002. Epub 2020 Nov 30.
10
F-Fluoromisonidazole positron emission tomography/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: A feasibility study.基于F-氟米索硝唑正电子发射断层扫描/计算机断层扫描引导的容积调强弧形放疗对鼻咽癌缺氧亚体积进行剂量递增的可行性研究。
Head Neck. 2017 Dec;39(12):2519-2527. doi: 10.1002/hed.24925. Epub 2017 Sep 30.

引用本文的文献

1
Evaluating the efficacy of biological versus physical cost functions with constrained mode for inverse plan optimization of head and neck cancer.评估生物成本函数与物理成本函数在约束模式下对头颈部癌逆向计划优化的疗效。
Radiol Phys Technol. 2025 Sep;18(3):851-860. doi: 10.1007/s12194-025-00939-6. Epub 2025 Jul 14.